Changes in intraocular pressure in study and fellow eyes in the IVAN trial. - Wikidata - awgldk - TriplyDB

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

http://www.wikidata.org/entity/Q37600185

about

Induced pluripotent stem cell-based therapy for age-related macular degeneration.

P2860

Q48218214-48621A1A-E6DF-4E9E-8796-513F00A334C2

P2860

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

http://www.wikidata.org/entity/Q37600185

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@en

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@nl

type

label

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@en

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@nl

prefLabel

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@en

Changes in intraocular pressure in study and fellow eyes in the IVAN trial.

@nl

P1433

Q37600185-CF374D29-F0A9-4EF4-A076-EC5CA1BD332A

P1476

Q37600185-6453B9C2-7E90-4AD0-9A25-9787B0FB5080

P2093

Q37600185-3B475D46-6A51-4BE0-9623-BC2E257DEEF1

Q37600185-658F33FA-B604-47FC-8E46-D790E3120A48

Q37600185-74414C3B-A2FE-4F55-822A-C002FD35D473

Q37600185-9A4C223C-AD0F-4A4F-B524-7553F259B105

Q37600185-E02A6381-8B82-4A47-B172-EAE6D9DA45CA

Q37600185-E965ECB1-1F5E-42F1-8937-71495FC98FF7

P2860

Q37600185-05095848-70EB-47FF-ABC2-10661B870FE4

Q37600185-1241CE4B-A10F-49AD-8C42-6764F64B1144

Q37600185-1937A6DB-7EDB-40B4-9024-0DB9F34CA168

Q37600185-1B6CF07A-150F-4EDF-B9A6-3F32A20895CB

Q37600185-441C40A1-4E09-4395-915E-E900AC4B67E6

Q37600185-4A014456-BEBA-4623-B64C-A2442D5B14E2

Q37600185-587473E7-8AC1-49BC-8706-C41EAC3D0EA5

Q37600185-8B2D5D1B-AA3E-452D-8F72-F7B573FF44F6

Q37600185-995D4875-3DFA-44CA-8959-78A092E970FC

Q37600185-A55E94E5-2850-408F-8B70-B25D7CB9DB6A

P304

Q37600185-7BB9CB7A-7D0A-4297-B237-6E27869CD4B8

P31

Q37600185-23A90F8D-0264-4A7E-82FE-D20E582E0F09

P356

Q37600185-ECA894DC-23DD-4456-ABA3-C951EE26B39A

P407

Q37600185-473C3D15-664B-45C9-A092-2D9A5E26AD40

P433

Q37600185-7B1190ED-1BA3-46DB-A4D0-DD00386301B7

P478

Q37600185-9E030727-5116-4DFB-BB09-5F9FDBF4CF62

P50

Q37600185-5D81914E-37DC-4482-B6D2-D91CCD4CC7B0

Q37600185-9AE27C08-504F-4BC2-82FD-9ED4A498DA6C

P577

Q37600185-97F6A66E-A0B7-4C56-8CA0-A1B981713379

P698

Q37600185-05DD8B48-1ECA-44A6-9063-509BEA191FDB

P932

Q37600185-BA0535FD-C413-4459-9327-51300A8853D6

P356

BJOPHTHALMOL-2015-307595

P1433

British Journal of Ophthalmology

P1476

Changes in intraocular pressure in study and fellow eyes in the IVAN trial

@en

P2093

Alexander J E Foss

http://www.w3.org/2001/XMLSchema#string

Barney C Reeves

http://www.w3.org/2001/XMLSchema#string

Chris A Rogers

http://www.w3.org/2001/XMLSchema#string

Faruque Ghanchi

http://www.w3.org/2001/XMLSchema#string

IVAN study group

http://www.w3.org/2001/XMLSchema#string

Lauren J Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections.

Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling

Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.

A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.

High intraocular pressure following anti-vascular endothelial growth factor therapy: proposed pathophysiology due to altered nitric oxide metabolism.

Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis.

Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy.

Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.

Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.

P304

1662-1667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJOPHTHALMOL-2015-307595

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Usha Chakravarthy

Jonathan M Gibson

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27073205

http://www.w3.org/2001/XMLSchema#string

P932

5256412

http://www.w3.org/2001/XMLSchema#string